Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Melanoma

  Free Subscription


05.02.2018

2 Anticancer Res
1 BMC Cancer
1 J Clin Oncol
1 J Invest Dermatol
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. BURGARD B, Schope J, Holzschuh I, Schiekofer C, et al
    Solarium Use and Risk for Malignant Melanoma: Meta-analysis and Evidence-based Medicine Systematic Review.
    Anticancer Res. 2018;38:1187-1199.
    PubMed     Text format     Abstract available

  2. GRECO M, Arcidiacono B, Chiefari E, Vitagliano T, et al
    HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.
    Anticancer Res. 2018;38:771-778.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. BUDDEN T, van der Westhuizen A, Bowden NA
    Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma.
    BMC Cancer. 2018;18:100.
    PubMed     Text format     Abstract available


    J Clin Oncol

  4. KHUSHALANI NI
    Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
    J Clin Oncol. 2018 Feb 1:JCO2017768275. doi: 10.1200/JCO.2017.76.8275.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  5. CARRERA C, Puig-Butille JA
    Clinical, Epidemiological, and Molecular Heterogeneity in Acral Melanoma.
    J Invest Dermatol. 2018;138:254-255.
    PubMed     Text format     Abstract available


    PLoS One

  6. WANG LX, Li Y, Chen GZ
    Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
    PLoS One. 2018;13:e0190447.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  7. TAGGART D, Andreou T, Scott KJ, Williams J, et al
    Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8(+) T cell trafficking.
    Proc Natl Acad Sci U S A. 2018 Jan 31. pii: 1714089115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: